Surgery

What Is Minimally Invasive Foot and Ankle Surgery?

Wednesday, May 27, 2020 - 10:00pm

Rosemont, Ill., May 27, 2020 (GLOBE NEWSWIRE) -- Minimally invasive surgery (MIS) is a technique used by foot and ankle orthopaedic surgeons to correct specific foot and ankle conditions with very small incisions.

Key Points: 
  • Rosemont, Ill., May 27, 2020 (GLOBE NEWSWIRE) -- Minimally invasive surgery (MIS) is a technique used by foot and ankle orthopaedic surgeons to correct specific foot and ankle conditions with very small incisions.
  • Peter G. Mangone, MD, a foot and ankle orthopaedic surgeon with Blue Ridge Bone & Joint Clinic in North Carolina, explains the difference between minimally invasive surgery and traditional open surgery.
  • If you have a foot or ankle condition, first consult with a foot and ankle orthopaedic surgeon to determine the best treatment option for you.
  • The American Orthopaedic Foot & Ankle Society (AOFAS) mobilizes our dynamic community of foot and ankle orthopaedic surgeons to improve patient care through education, research, and advocacy.

According to THE SAGE GROUP, Treating Critical Limb Ischemia (CLI) with Major Amputation Costs Over $22 Billion, Results in a Significant Misallocation of Healthcare Resources and Wastes Taxpayer Dollars

Wednesday, May 27, 2020 - 7:37pm

This reflects its high costs, lower cost-effectiveness than revascularization and abysmal patient outcomes , emphasized Yost.

Key Points: 
  • This reflects its high costs, lower cost-effectiveness than revascularization and abysmal patient outcomes , emphasized Yost.
  • It is commonly believed that amputation costs the hospital less than revascularization procedures.
  • Our analysis , as well as other research, demonstrates that amputation actually costs the hospital more than either surgical bypass or endovascular revascularization.
  • Since the procedure is not cost-effective, this represents a misallocation of scarce healthcare resources and a waste of taxpayer dollars, declared Ms. Yost.

InfiniteMD Launches Virtual Center of Excellence Programs to Enhance Longitudinal Access to the Leading Expert Multidisciplinary Teams of Specialists in U.S.

Wednesday, May 27, 2020 - 7:27pm

InfiniteMD , a leader in virtual expert opinions, today announces the launch of its new Virtual Center of Excellence (VCOE) programs, which pair individuals with an expert multidisciplinary team of up to five physicians for remote expert opinions.

Key Points: 
  • InfiniteMD , a leader in virtual expert opinions, today announces the launch of its new Virtual Center of Excellence (VCOE) programs, which pair individuals with an expert multidisciplinary team of up to five physicians for remote expert opinions.
  • Studies have previously demonstrated that the ongoing collaboration of an expert multidisciplinary team produces the greatest improvements in quality of life and outcomes for patients.
  • InfiniteMD has developed these VCOE programs and platform enhancements with the guidance of highly engaged experts at centers of excellence across the country.
  • They represent physician champions of the platform and have evangelized their colleagues around innovation in delivering multidisciplinary remote expert opinions.

Orthopaedic Institute for Children’s Ambulatory Surgery Center and OIC Laboratory Receive National Accreditations

Wednesday, May 27, 2020 - 4:05pm

The Ambulatory Surgery Center at Orthopaedic Institute for Children has achieved renewed accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC).

Key Points: 
  • The Ambulatory Surgery Center at Orthopaedic Institute for Children has achieved renewed accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC).
  • Additionally, the OIC Laboratory has been accredited by The Joint Commission in recognition of it meeting and exceeding rigorous performance standards.
  • Opened in 2016, the Ambulatory Surgery Center on OICs downtown Los Angeles campus is the first center in Los Angeles designed and built exclusively to provide orthopaedic outpatient surgical care to children.
  • The center has been shown to reduce orthopaedic surgery wait times while greatly enhancing quality outcomes and enriching the patient experience for children and their parents.

Centricity Vision Introduces New Name and Leadership Team

Wednesday, May 27, 2020 - 2:00pm

Centricity Vision reflects the companys core competency, embodied by its ZEPTO Precision Cataract Surgery Platform, in creating precise, consistent, visual axis-centered capsulotomies.

Key Points: 
  • Centricity Vision reflects the companys core competency, embodied by its ZEPTO Precision Cataract Surgery Platform, in creating precise, consistent, visual axis-centered capsulotomies.
  • This seasoned team leverages extensive experience in the ophthalmology and medical device industries to drive technological innovation, product quality and commercial success.
  • Based in Carlsbad, Calif., Centricity Vision is a global ophthalmic technology company dedicated to providing surgeons with innovative solutions that enhance procedural excellence.
  • Developer of the U.S. and internationally approved ZEPTO Precision Cataract Surgery Platform, Centricity Vision is committed to providing high-quality, cost-effective solutions to assist physicians in delivering the best possible vision care to patients.

NAPA Completes Eighth Annual Get Back and Give Back Campaign to Support the Intrepid Fallen Heroes Fund

Wednesday, May 27, 2020 - 2:00pm

NAPA AUTO PARTS announced today that it has completed its eighth annual Get Back and Give Back Campaign.

Key Points: 
  • NAPA AUTO PARTS announced today that it has completed its eighth annual Get Back and Give Back Campaign.
  • NAPA AUTO PARTS stores and NAPA AutoCare Centers partnered in multiple promotional programs in 2019 to raise money for the IFHF.
  • The Get Back and Give Back Campaign makes NAPA one of the single largest donors to the Fund.
  • The Intrepid Fallen Heroes Fund (IFHF) is a leader in supporting the men and women of the United States armed forces and their families.

Titan Medical Receives Nasdaq Delisting Notification and Discloses Plans for Appeal

Wednesday, May 27, 2020 - 1:00pm

A hearing request will stay the delisting of the Company's securities until a determination is made by the Panel.

Key Points: 
  • A hearing request will stay the delisting of the Company's securities until a determination is made by the Panel.
  • The Companys common shares will continue to trade on the Nasdaq Capital Market pending the outcome of the hearing before the Panel.
  • The Company will address the ongoing non-compliance matters before the Panel and will request additional time to cure the Deficiency.
  • This announcement is made in compliance with Nasdaq Listing Rule 5810(b) which requires prompt disclosure of receipt of a Staff Delisting Determination.

Study Confirms Safety, Durability of PROCEPT BioRobotics’ Aquablation Therapy in Large Prostates at Two Years

Wednesday, May 27, 2020 - 12:00pm

In addition, two-year WATER II data confirm that Aquablation therapy provides considerable operating time efficiencies and durable, consistent outcomes with a low learning curve.

Key Points: 
  • In addition, two-year WATER II data confirm that Aquablation therapy provides considerable operating time efficiencies and durable, consistent outcomes with a low learning curve.
  • WATER II (Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue) was a prospective multicenter international clinical trial evaluating Aquablation therapy in 101 men with large prostates 80 to 150 cc in size.
  • Aquablation therapy combines real-time, multi-dimensional imaging, automated robotics and heat-free waterjet ablation for targeted, controlled, and immediate removal of prostate tissue.
  • For more information about potential side effects and risks associated with Aquablation therapy, speak with your urologist or surgeon.

Global Surgical Table Market (2019 to 2024) - Featuring Skytron, Steris & Denyers International Among Others - ResearchAndMarkets.com

Wednesday, May 27, 2020 - 9:31am

The technologies in surgical table have undergone significant change in recent years, with manually operated to hybrid surgical tables.

Key Points: 
  • The technologies in surgical table have undergone significant change in recent years, with manually operated to hybrid surgical tables.
  • The rising wave of new technology such as hybrid surgical table technology is creating significant potential for advanced surgical table in various medical platforms as minimally invasive surgery creates a need for technologically advanced operating tables.
  • In surgical table market, various technologies such as non-powered/manual, powered, and hybrid technologies are used in the general, radiolucent, specialty, orthopedic, laparoscopic, neurosurgical, bariatric, and pediatric operating table applications.
  • This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the surgical table market.

Intersect ENT to Present at the William Blair 40th Annual Growth Stock Conference

Tuesday, May 26, 2020 - 9:15pm

Intersect ENT, Inc. (Nasdaq: XENT ), today announced that management will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference.

Key Points: 
  • Intersect ENT, Inc. (Nasdaq: XENT ), today announced that management will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference.
  • To access the webcast, go to the "Investor Relations" page of the Company's website at www.intersectENT.com .
  • Intersect ENT is a company transforming care for patients with ear, nose and throat conditions.
  • Intersect ENT, PROPEL and SINUVA are registered trademarks of Intersect ENT, Inc.